US Patent Issued to AMS Therapeutics on April 14 for "Method of treating expressive language deficit in autistic humans" (California Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,581, issued on April 14, was assigned to AMS Therapeutics (Pasadena, Calif.).

"Method of treating expressive language deficit in autistic humans" was invented by Charles E. Niesen (Pasadena, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmacological method for treating the expressive language deficit in an autistic human child or adult is provided. A therapeutically effective dose of a succinimide anticonvulsant, e.g., ethosuximide, methsuximide, phensuximide, or a pharmaceutically acceptable salt thereof, is administered to a patient suffering from expressive language deficit, preferably over an extended period, e.g., six months or lo...